Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher toutes les espèces
Afficher tous les synonymes
Sélectionnez vos espèces et l'application
anti-Mouse (Murine) FGF2 Anticorps:
anti-Rat (Rattus) FGF2 Anticorps:
anti-Human FGF2 Anticorps:
Vous arrivez à notre recherche pré-filtrée.
Guinea Pig Polyclonal FGF2 Primary Antibody pour IF (cc), IF (p) - ABIN726425
Pan, Wang, Xiang, Shao: Delta-like 1 serves as a new target and contributor to liver fibrosis down-regulated by mesenchymal stem cell transplantation. dans The Journal of biological chemistry 2011
Show all 12 Pubmed References
Chicken Monoclonal FGF2 Primary Antibody pour IF, IP - ABIN967725
Estival, Monzat, Miquel, Gaubert, Hollande, Korc, Vaysse, Clemente: Differential regulation of fibroblast growth factor (FGF) receptor-1 mRNA and protein by two molecular forms of basic FGF. Modulation of FGFR-1 mRNA stability. dans The Journal of biological chemistry 1996
Show all 5 Pubmed References
Chicken Monoclonal FGF2 Primary Antibody pour IF, IP - ABIN967726
Fox, Shanley: Antisense inhibition of basic fibroblast growth factor induces apoptosis in vascular smooth muscle cells. dans The Journal of biological chemistry 1996
Show all 5 Pubmed References
Human Polyclonal FGF2 Primary Antibody pour ELISA, IHC (p) - ABIN3042812
Wang, Wang, Yao, Wu, Tang, Gu, Li: The fibroblast growth factor-2 arrests Mycobacterium avium sp. paratuberculosis growth and immunomodulates host response in macrophages. dans Tuberculosis (Edinburgh, Scotland) 2015
Show all 3 Pubmed References
Human Monoclonal FGF2 Primary Antibody pour IHC, ELISA - ABIN969137
Romanov, James, Sherrington, Pettitt: Basic fibroblast growth factor suppresses p53 activation in the neoplastic cells of a proportion of patients with chronic lymphocytic leukaemia. dans Oncogene 2005
Show all 3 Pubmed References
Human Polyclonal FGF2 Primary Antibody pour WB - ABIN3042390
Zhou, Ma, Si, Li, Xu, Tu, Wang: MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth. dans Cancer letters 2013
Show all 3 Pubmed References
Human Monoclonal FGF2 Primary Antibody pour IHC, ELISA - ABIN966137
Kim, Shin, Choi, Kim, Ahn, Lee, Park, Kim, Mok, Nam: A preliminary results of a randomized trial comparing monthly 5-flourouracil and cisplatin to weekly cisplatin alone combined with concurrent radiotherapy for locally advanced cervical cancer. dans Cancer research and treatment : official journal of Korean Cancer Association 2009
Show all 2 Pubmed References
Human Monoclonal FGF2 Primary Antibody pour IHC (fro), ELISA - ABIN2473612
Kalsheker, Watkins, Hill, Morgan, Stockley, Fick: Independent mutations in the flanking sequence of the alpha-1-antitrypsin gene are associated with chronic obstructive airways disease. dans Disease markers 1991
Show all 4 Pubmed References
Cow (Bovine) Polyclonal FGF2 Primary Antibody pour IHC (p), IHC - ABIN269699
de Ruijter-Villani, van Boxtel, Stout: Fibroblast growth factor-2 expression in the preimplantation equine conceptus and endometrium of pregnant and cyclic mares. dans Theriogenology 2013
Show all 2 Pubmed References
Human Monoclonal FGF2 Primary Antibody pour IF, IHC - ABIN2452348
Pickard, Adams, Barraud, Chari: Using magnetic nanoparticles for gene transfer to neural stem cells: stem cell propagation method influences outcomes. dans Journal of functional biomaterials 2015
Thus, FGF-2 levels in hESCs culture systems can be manipulated to generate cells with longer telomere which would be advantageous in the applications of hESCs in regenerative medicine.
Low FGF2 expression is associated with cardiac ischemia and systolic dysfunction.
Mechanical strain stimulates vasculogenesis of embryonic stem cells by the intracellular messengers ROS (Montrer ROS1 Anticorps), NO and calcium as well as by upregulation of angiogenesis guidance molecules and the angiogenic growth factors VEGF (Montrer VEGFA Anticorps), FGF-2 and PDGF (Montrer PDGFA Anticorps)-BB.
FGFR (Montrer FGFR2 Anticorps) Inhibitor Ameliorates Hypophosphatemia and Impaired Engrailed-1/Wnt (Montrer WNT2 Anticorps) Signaling in FGF2 High Molecular Weight Isoform
data suggest that FGF2 levels are critically related to anxiety behavior and hypothalamic pituitary- adrenal axis activity, likely through modulation of hippocampal glucocorticoid receptor (Montrer NR3C1 Anticorps) expression, an effect that is likely receptor mediated, albeit not by FGFR1 (Montrer FGFR1 Anticorps), FGFR2 (Montrer FGFR2 Anticorps), and FGFR3 (Montrer FGFR3 Anticorps).
The differentiation of ERF-overexpressing trophoblast stem cell lines also suggests that ERF may have an FGF2-independent effect during the commitment towards syncytiotrophoblasts.
Novel VF-Trap fusion protein on blockage of VEGF (Montrer VEGFA Anticorps) and FGF-2 activity to prevent angiogenesis.
FGF2 is an extracellular inducer of COUP-TFII (Montrer NR2F2 Anticorps) expression and may suppress the osteogenic potential of mesenchymal cells by inducing COUP-TFII (Montrer NR2F2 Anticorps) expression prior to the onset of osteogenic differentiation
clearly demonstrate the different specificity of FGF12 (Montrer FGF12 Anticorps)-FGFR1c2 and FGF22 (Montrer FGF22 Anticorps)-FGFR1c2 for well defined HS structures and suggest that it is now possible to chemoenzymatically synthesize precise HS polysaccharides that can selectively mediate growth factor signaling
These results support that controlling the aberrant expression of TGF-beta1 (Montrer TGFB1 Anticorps) and FGF-2 via inhibition of Wnt (Montrer WNT2 Anticorps)/beta-catenin (Montrer CTNNB1 Anticorps) signaling could serve as a potential therapeutic strategy for pulmonary fibrosis.
Results uncover a novel Sdc2 (Montrer SDC2 Anticorps)-Tbx16-Fgf2 pathway that regulates epithelial cell morphogenesis.
Taken together, Staphylococcus aureus induces TGF-beta1 (Montrer TGFB1 Anticorps) and bFGF expression through the activation of AP-1 (Montrer JUN Anticorps) and NF-kappaB (Montrer NFKB1 Anticorps) in bovine mammary gland fibroblasts.
Data suggest THBS1 (thrombospondin-1 (Montrer THBS1 Anticorps)) expression predominates in luteal endothelial cells; THBS2 (Montrer THBS2 Anticorps) expression predominates in luteinized granulosa cells. Luteinizing signals down-regulate expression of THBS1 (Montrer THBS1 Anticorps)/THBS2 (Montrer THBS2 Anticorps) but up-regulate expression of FGF2.
Mixed populations of luteal cells were treated with SU1498 (VEGF receptor 2 inhibitor) or SU5402 (FGF receptor 1 inhibitor) or control on days 0-3, 3-6 or 6-9 to determine the role of FGF2 and VEGFA (Montrer VEGFA Anticorps) during these specific windows.
FGF2 was crucial for luteal endothelial network formation.
Associations between reproduction and milk traits, and polymorphisms at the STAT5A (Montrer STAT5A Anticorps) and FGF2 gene loci, were found with STAT5A (Montrer STAT5A Anticorps) polymorphism for age at first calving (suggestive effect; P =0.077) and lactation milk yield (significant effect; P<0.05).
FGF2 and FGF10 (Montrer FGF10 Anticorps) regulate migratory activity of ovine trophoblast cells through MAPK (Montrer MAPK1 Anticorps)-dependent pathways.
investigation of signaling mechanisms used by FGF2 to regulate interferon-tau (IFNT) production in trophoblasts: several lines of evidence suggest that FGF2 regulates IFNT production in trophoblasts by acting through protein kinase C-delta (Montrer PKCd Anticorps)
Alterations in the expression of VEGF-A (Montrer VEGFA Anticorps) and bFGF systems suggest that angiogenic factors are involved in abnormal placental development in cloned gestations, contributing to impaired fetal development and poor survival rates.
bFGF is oxidized by lysyl oxidase (Montrer LOX Anticorps)
vascular endothelial growth factor indirectly stimulates smooth muscle cell proliferation and migration through the modulation of basic fibroblast growth factor and transforming growth factor beta(1 (Montrer TGFB1 Anticorps)) released by endothelial cells
In an in vitro assay of vascular smooth muscle cells, circRNA WDR77 (Montrer WDR77 Anticorps) silencing significantly inhibited cell proliferation and migration. Bioinformatics methods revealed that miR (Montrer MLXIP Anticorps)-124 and fibroblast growth factor 2 (FGF-2) were downstream targets of circRNA WDR77 (Montrer WDR77 Anticorps).
FGF2 protects the tumor cells from the antiproliferative effect of Gefitinib and largely prevents reprogramming of the proteome and phosphoproteome
High FGF2 expression is associated with colon cancer metastasis.
FGF1 and 2 strongly prevent the osteogenic commitment and differentiation of hBMSCs.
These observations identify airway smooth muscle cells -derived FGF2b as a factor needed for LMC formation by CD4 (Montrer CD4 Anticorps) T cells, affecting intercellular communication.
Report no relationship between serum bFGF levels and ovarian cancer microvessel density and tumor bFGF expression.
High FGF2 expression is associated with ovarian cancer.
The antitumor activity of scopoletin may be due to its strong anti-angiogenic effect, which may be mediated by its effective inhibition of ERK1 (Montrer MAPK3 Anticorps), VEGF-A (Montrer VEGFA Anticorps), and FGF-2.
TGF-beta (Montrer TGFB1 Anticorps), bFGF and epimorphin (Montrer STX2 Anticorps) in the extracellular microenvironment cooperatively affect HSF (Montrer HSF1 Anticorps) behaviors under the control of a highly sulfated (Montrer SULF1 Anticorps) chondroitin sulfate
High FGF2 expression is associated with lung cancer.
Continuous passive motion can promote b-FGF expression to enhance type III collagen (Montrer COL3A1 Anticorps) synthesis at the tendon-bone interface in early stage of tendon-bone repair following acute rupture of supraspinatus tendon in rabbits.
Fibroblast growth factor-2 promotes in vitro heart valve interstitial cell repair through the Akt1 (Montrer AKT1 Anticorps) pathway.
The overlapping relationships of 3'UTR (Montrer UTS2R Anticorps) ends between NUDT6 (Montrer NUDT6 Anticorps) and FGF-2 genes, were analyzed.
FGF2 in porcine ovary may be important for the growth of more follicles due to the localisation and concentration difference between stroma and follicle tissue.
By inducing the release of an endothelial elastase, shear stress induces an integrin-dependent release of FGF-2 from endothelial cells.
qPCR analysis demonstrated an increase in FGF-2 mRNA levels beginning on day 75 and on day 114 of pregnancy.
FGF2 activates FGFR (Montrer FGFR2 Anticorps) which then represses the fibroblast activation of valvular interstitial cells.
FGF2 effectively blocks transforming growth factor-beta1 (TGF-beta1 (Montrer TGFB1 Anticorps))-mediated myofibroblast activation
upregulation of TGFalpha or FGF2 expression is not a pre-requisite for enhanced testicular growth and increased Sertoli cell proliferation that occurs subsequent to hemicastration in the neonatal boar
These results suggest that bFGF activation of neuronal FGFR1 (Montrer FGFR1 Anticorps) generates filopodial processes in neurons that promote nerve-muscle interaction and facilitate NMJ establishment.
The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members bind heparin and possess broad mitogenic and angiogenic activities. This protein has been implicated in diverse biological processes, such as limb and nervous system development, wound healing, and tumor growth. The mRNA for this gene contains multiple polyadenylation sites, and is alternatively translated from non-AUG (CUG) and AUG initiation codons, resulting in five different isoforms with distinct properties. The CUG-initiated isoforms are localized in the nucleus and are responsible for the intracrine effect, whereas, the AUG-initiated form is mostly cytosolic and is responsible for the paracrine and autocrine effects of this FGF.
, basic fibroblast growth factor
, heparin-binding growth factor 2
, fibroblast growth factor 2
, basic fibroblast growth factor bFGF
, Basic fibroblast growth factor
, Heparin-binding growth factor 2